🇺🇸 FDA
Pipeline program

Casodex 50 mg Film-coated Tablets, Zoladex 10,8 mg implantat

SHR-3680-III-HSPC

Phase 3 small_molecule active

Quick answer

Casodex 50 mg Film-coated Tablets, Zoladex 10,8 mg implantat for Metastatic hormone-sensitive prostate cancer with high tumor load is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Metastatic hormone-sensitive prostate cancer with high tumor load
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials